Company Current Liabilities: Evolus Inc (EOLS)

EOLS (evolus.com) - company brandmark

Historical price action for Evolus, Inc. (EOLS) on the GURU.Markets platform demonstrates the impact of high business scalability focused on high-demand botulinum toxin, which minimizes development costs. Growth is supported by the expansion of aesthetic neurotoxins, which are actively displacing older analogs among younger demographics. The current short-term debt metric stands at 0.00, confirming the company's resilience within the healthcare sector.

EOLS evolus.com Company Current Liabilities (07/04/2022 - 10/30/2026)

Financial and market metric breakdowns for Evolus Corp (EOLS)

- stock price and consensus target price:
Stock Price Evolus|EOLS - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Valuation Evolus, Inc.|EOLS - Aggregate Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Evolus|EOLS - Company Net Assets|Market Capitalization to Book Value Ratio evolus.com|EOLS - Company Assets
- business debt structure and liquidity details:
Debt to Equity Evolus, Inc.|EOLS - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Evolus, Inc.|EOLS - Company Cumulative Indebtedness|Debts to Book Capitalization Evolus, Inc.|EOLS - Long-Term Debt|Company Current Liabilities Evolus|Quick Liquidity evolus.com
- earnings and multiples data:
EOLS - Company Net Income
Summary company analytics:Evolus (EOLS)
Mass-produced product of evolus.com

Evolus, Inc. (EOLS) is actively scaling its digital platform and expanding the clinical indications for Jeuveau. Such capital-intensive R&D investments directly impact the structure of current liabilities. This indicator aggregates all debts maturing within one year to assess the risk of a liquidity gap. A decrease in this metric may signal either financial recovery or a reduction in expansion. Analyze the total amount of short-term debt to monitor operational liquidity.

Main competitors

HCA Holdings - Company Short-Term Debts|THC - Company Short-Term Debts|FMS (Fresenius Medical Care Corp) - Company Current Liabilities|SOLV: Amount of Current Liabilities|Company Short-Term Debt Encompass Health|Company Current Liabilities Universal Health Services Corp (UHS)|Company Short-Term Debts DVA|RDNT - Short-Term Debt|Company Short-Term Debt Option Care Health Inc OPCH|SGRY: Company Short-Term Indebtedness|PINC: Company Current Liabilities|nationalvision.com - Amount of Current Liabilities|PGNY: Company Short-Term Debts|Short-Term Debt Ardent Health (ARDT)|Company Current Liabilities SEM|Company Short-Term Debt ASTH|Company Short-Term Debt Pediatrix Medical Group (MD)|USPH - Short-Term Debt|Company Short-Term Debt The Pennant Group PNTG|Organogenesis Holdings Inc. - Company Short-Term Debt|NUTX: Company Current Liabilities|AUNA - Company Short-Term Debts|sbc-holdings.com (SBC) - Company Short-Term Debt|CYH - Short-Term Debt Volume|Company Current Liabilities SKIN|MDWD: Company Short-Term Loans and Borrowings|Company Short-Term Debts BTMD|Short-Term Debt Volume The Joint|Company Short-Term Debt DocGo Inc. DCGO|PIII: Company Short-Term Indebtedness|Gain Therapeutics, Inc. - Company Short-Term Debts|euda.com (EUDA) - Company Current Liabilities|BMGL (baselmedical.com) - Company Current Liabilities|CLGN - Short-Term Debt Volume|CUPR (Cuprina Holdings (Cayman) Ltd) - Company Short-Term Debts|Short-Term Debt concordmedical.com CCM|Company Short-Term Debt American Shared Hospital Services (AMS)|MRM - Short-Term Debt|Company Short-Term Debt Avalon GloboCare Corp. ALBT|DIH Group - Company Short-Term Debt|XAGE - Company Short-Term Debt|Short-Term Debt Volume newgenivf.com NIVF|ATIP (atipt.com) - Company Current Liabilities|CMAX: Amount of Current Liabilities|Company Short-Term Debt Kindly MD Corp|MODV: Company Short-Term Loans and Borrowings|Company Short-Term Debts NVOS|SSY - Short-Term Debt|Company Short-Term Debts BACK (IMAC Holdings)